DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Sorivudine is an investigational drug.
There have been 6 clinical trials for Sorivudine. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 1997.
The most common disease conditions in clinical trials are Herpes Zoster, Chickenpox, and Rectal Neoplasms. The leading clinical trial sponsors are Bristol-Myers Squibb, M.D. Anderson Cancer Center, and Genentech, Inc.
Recent Clinical Trials for Sorivudine
|Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)||aRigen Pharmaceuticals, Inc.||Phase 2|
|Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer||Genentech, Inc.||Phase 1|
|Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer||M.D. Anderson Cancer Center||Phase 1|